Showing 23,061 - 23,080 results of 113,932 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((point decrease) OR (fold decrease)) ))', query time: 1.15s Refine Results
  1. 23061

    Image_2_Hsa_circ_0060927 Is a Novel Tumor Biomarker by Sponging miR-195-5p in the Malignant Transformation of OLK to OSCC.tif by Siming Xu (11928773)

    Published 2022
    “…</p>Conclusion<p>Hsa_circ_0060927 acted as a potential key ceRNA to sponge downstream miR-195-5p and promote OLK carcinogenesis by upregulating TRIM14. …”
  2. 23062

    Image_1_Hsa_circ_0060927 Is a Novel Tumor Biomarker by Sponging miR-195-5p in the Malignant Transformation of OLK to OSCC.tif by Siming Xu (11928773)

    Published 2022
    “…</p>Conclusion<p>Hsa_circ_0060927 acted as a potential key ceRNA to sponge downstream miR-195-5p and promote OLK carcinogenesis by upregulating TRIM14. …”
  3. 23063
  4. 23064
  5. 23065

    Glycosylation of a Fasciclin-Like Arabinogalactan-Protein (SOS5) Mediates Root Growth and Seed Mucilage Adherence via a Cell Wall Receptor-Like Kinase (FEI1/FEI2) Pathway in Arabid... by Debarati Basu (739130)

    Published 2016
    “…Notably, <i>galt2galt5</i> double mutants displayed impaired root growth and root tip swelling in response to salt, likely as a result of decreased cellulose synthesis. …”
  6. 23066

    A mechanistic mathematical model of HIV primary infection including VRC01. by Daniel B. Reeves (8407932)

    Published 2020
    “…Susceptible cells decrease by approximately 200 cells/<i>μ</i>L and reconstitute by viral set-point. …”
  7. 23067

    RNAi-based screen for genes that modify aSyn oligomerization in living cells. by Susana A. Gonçalves (199613)

    Published 2016
    “…</b> Representative live cell imaging pictures of aSyn-BiFC stable H4 cells silenced for hits that increase (<i>RAB8B</i>, <i>RAB11A</i>, <i>RAB13</i>, <i>RAB39B</i>, <i>CAMK1</i>, <i>DYRK2</i>) or decrease (<i>CC2D1A</i>, <i>CLK4</i>, <i>SYTL5)</i> aSyn oligomerization (green). …”
  8. 23068

    Table_1_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.DOCX by Zhi-Ming Ding (3637720)

    Published 2020
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  9. 23069

    Image_2_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.PDF by Zhi-Ming Ding (3637720)

    Published 2018
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  10. 23070

    Image_2_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.PDF by Zhi-Ming Ding (3637720)

    Published 2020
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  11. 23071

    Table_1_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.DOCX by Zhi-Ming Ding (3637720)

    Published 2018
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  12. 23072

    Table_2_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.DOCX by Zhi-Ming Ding (3637720)

    Published 2018
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  13. 23073

    Image_1_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.PDF by Zhi-Ming Ding (3637720)

    Published 2020
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  14. 23074

    Image_1_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.PDF by Zhi-Ming Ding (3637720)

    Published 2018
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  15. 23075

    Table_2_Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.DOCX by Zhi-Ming Ding (3637720)

    Published 2020
    “…Anti-inflammation drug Cenicriviroc, on the other hand, markedly decreased inflammation and hepatocyte degeneration, and mildly decreased liver fibrosis, but exhibited no effect on hepatic steatosis/macrovesicular vacuolation. …”
  16. 23076

    Retinal Proteome Analysis in a Mouse Model of Oxygen-Induced Retinopathy by Sang Jin Kim (410335)

    Published 2012
    “…To identify proteins that are involved in the molecular mechanisms of oxygen-induced retinopathy (OIR), a well-established model of blinding ischemic retinopathy, we quantitatively analyzed the retinal proteome in a mouse model of OIR. …”
  17. 23077
  18. 23078
  19. 23079
  20. 23080

    Oligonucleotides used in this study. by Chawalit Chatupheeraphat (17404014)

    Published 2024
    “…Interestingly, BLIP-II-CPP exhibited the highest inhibitory activity, reducing the minimal inhibitory concentration (MIC) of meropenem by 8 folds. Moreover, the combination of tBLIP-CPP with meropenem significantly decreased the viable bacterial cell count compared to the combination of tBLIP-II with meropenem or meropenem alone. …”